Arecor Therapeutics Future Growth
Future criteria checks 2/6
Arecor Therapeutics is forecast to grow earnings and revenue by 49.1% and 35.8% per annum respectively while EPS is expected to grow by 53.6% per annum.
Key information
49.1%
Earnings growth rate
53.6%
EPS growth rate
Biotechs earnings growth | 27.7% |
Revenue growth rate | 35.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 20 May 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 15 | -1 | N/A | -2 | 1 |
12/31/2025 | 11 | -4 | -3 | -3 | 3 |
12/31/2024 | 7 | -6 | -5 | -6 | 3 |
12/31/2023 | 5 | -9 | -6 | -6 | N/A |
9/30/2023 | 4 | -9 | -9 | -8 | N/A |
6/30/2023 | 3 | -9 | -11 | -11 | N/A |
3/31/2023 | 3 | -9 | -11 | -11 | N/A |
12/31/2022 | 2 | -9 | -11 | -11 | N/A |
9/30/2022 | 2 | -8 | -10 | -9 | N/A |
6/30/2022 | 1 | -7 | -8 | -8 | N/A |
3/31/2022 | 1 | -7 | -7 | -7 | N/A |
12/31/2021 | 1 | -6 | -6 | -5 | N/A |
9/30/2021 | 1 | -5 | -4 | -4 | N/A |
6/30/2021 | 1 | -5 | -3 | -3 | N/A |
3/31/2021 | 2 | -4 | -3 | -2 | N/A |
12/31/2020 | 2 | -3 | -2 | -2 | N/A |
12/31/2019 | 2 | -2 | 0 | 0 | N/A |
5/31/2019 | 1 | -2 | -3 | -3 | N/A |
5/31/2018 | 1 | -1 | -1 | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AREC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AREC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AREC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AREC's revenue (35.8% per year) is forecast to grow faster than the UK market (3.7% per year).
High Growth Revenue: AREC's revenue (35.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AREC's Return on Equity is forecast to be high in 3 years time